PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxa4
|
ENSMUSG00000000942.11 | Hoxa4 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hoxa4 | mm39_v1_chr6_-_52168675_52168733 | -0.50 | 9.1e-06 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr18_+_61096660 | 15.14 |
ENSMUST00000039904.7
|
Camk2a
|
calcium/calmodulin-dependent protein kinase II alpha |
chr18_+_61096597 | 14.83 |
ENSMUST00000115295.9
|
Camk2a
|
calcium/calmodulin-dependent protein kinase II alpha |
chr3_+_7494108 | 11.76 |
ENSMUST00000193330.2
|
Pkia
|
protein kinase inhibitor, alpha |
chrX_+_135723531 | 11.75 |
ENSMUST00000113085.2
|
Plp1
|
proteolipid protein (myelin) 1 |
chrX_+_135723420 | 11.35 |
ENSMUST00000033800.13
|
Plp1
|
proteolipid protein (myelin) 1 |
chr4_-_61259997 | 9.38 |
ENSMUST00000071005.9
ENSMUST00000075206.12 |
Mup14
|
major urinary protein 14 |
chr11_+_56902658 | 9.19 |
ENSMUST00000094179.11
|
Gria1
|
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
chr13_+_46655324 | 9.06 |
ENSMUST00000021802.16
|
Cap2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
chr12_-_46863726 | 8.81 |
ENSMUST00000219330.2
|
Nova1
|
NOVA alternative splicing regulator 1 |
chr13_-_78344492 | 8.77 |
ENSMUST00000125176.3
|
Nr2f1
|
nuclear receptor subfamily 2, group F, member 1 |
chr4_-_60222580 | 8.70 |
ENSMUST00000095058.5
ENSMUST00000163931.8 |
Mup8
|
major urinary protein 8 |
chr4_-_61259801 | 8.46 |
ENSMUST00000125461.8
|
Mup14
|
major urinary protein 14 |
chr12_+_38830283 | 8.42 |
ENSMUST00000162563.8
ENSMUST00000161164.8 ENSMUST00000160996.8 |
Etv1
|
ets variant 1 |
chr12_+_38830812 | 8.40 |
ENSMUST00000160856.8
|
Etv1
|
ets variant 1 |
chr11_+_56902624 | 8.14 |
ENSMUST00000036315.16
|
Gria1
|
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
chr13_+_58955506 | 7.82 |
ENSMUST00000079828.7
|
Ntrk2
|
neurotrophic tyrosine kinase, receptor, type 2 |
chr12_-_31763859 | 7.63 |
ENSMUST00000057783.6
ENSMUST00000236002.2 ENSMUST00000174480.3 ENSMUST00000176710.2 |
Gpr22
|
G protein-coupled receptor 22 |
chr3_+_114874614 | 7.59 |
ENSMUST00000051309.9
|
Olfm3
|
olfactomedin 3 |
chr5_-_84565218 | 7.52 |
ENSMUST00000113401.4
|
Epha5
|
Eph receptor A5 |
chr2_+_170573727 | 7.43 |
ENSMUST00000029075.5
|
Dok5
|
docking protein 5 |
chr17_+_93506435 | 7.37 |
ENSMUST00000234646.2
ENSMUST00000234081.2 |
Adcyap1
|
adenylate cyclase activating polypeptide 1 |
chr2_+_70393782 | 7.26 |
ENSMUST00000123330.3
|
Gad1
|
glutamate decarboxylase 1 |
chr11_+_97732108 | 7.12 |
ENSMUST00000155954.3
ENSMUST00000164364.2 ENSMUST00000170806.2 |
B230217C12Rik
|
RIKEN cDNA B230217C12 gene |
chr2_+_177969456 | 6.83 |
ENSMUST00000133267.3
|
Phactr3
|
phosphatase and actin regulator 3 |
chr6_-_138404076 | 6.79 |
ENSMUST00000203435.3
|
Lmo3
|
LIM domain only 3 |
chr13_+_42834039 | 6.78 |
ENSMUST00000128646.8
|
Phactr1
|
phosphatase and actin regulator 1 |
chr17_+_93506590 | 6.60 |
ENSMUST00000064775.8
|
Adcyap1
|
adenylate cyclase activating polypeptide 1 |
chr6_-_138403732 | 6.60 |
ENSMUST00000162932.2
|
Lmo3
|
LIM domain only 3 |
chr18_-_32082624 | 6.56 |
ENSMUST00000064016.6
|
Gpr17
|
G protein-coupled receptor 17 |
chr4_-_149211145 | 6.43 |
ENSMUST00000030815.3
|
Cort
|
cortistatin |
chr18_+_37488174 | 6.33 |
ENSMUST00000192867.2
ENSMUST00000051163.3 |
Pcdhb8
|
protocadherin beta 8 |
chr6_-_92511836 | 6.23 |
ENSMUST00000113446.8
|
Prickle2
|
prickle planar cell polarity protein 2 |
chr14_-_51134930 | 6.02 |
ENSMUST00000227271.2
|
Klhl33
|
kelch-like 33 |
chr8_-_68427217 | 5.97 |
ENSMUST00000098696.10
ENSMUST00000038959.16 ENSMUST00000093469.11 |
Psd3
|
pleckstrin and Sec7 domain containing 3 |
chr1_-_180021218 | 5.90 |
ENSMUST00000159914.8
|
Coq8a
|
coenzyme Q8A |
chr1_-_180021039 | 5.72 |
ENSMUST00000160482.8
ENSMUST00000170472.8 |
Coq8a
|
coenzyme Q8A |
chr7_-_19432933 | 5.66 |
ENSMUST00000174355.8
ENSMUST00000172983.8 ENSMUST00000174710.2 ENSMUST00000003066.16 ENSMUST00000174064.9 |
Apoe
|
apolipoprotein E |
chr16_+_37400590 | 5.63 |
ENSMUST00000159787.8
|
Hgd
|
homogentisate 1, 2-dioxygenase |
chr16_+_37400500 | 5.59 |
ENSMUST00000160847.2
|
Hgd
|
homogentisate 1, 2-dioxygenase |
chr13_+_58956077 | 5.53 |
ENSMUST00000109838.10
|
Ntrk2
|
neurotrophic tyrosine kinase, receptor, type 2 |
chr12_+_38831093 | 5.52 |
ENSMUST00000161513.9
|
Etv1
|
ets variant 1 |
chr6_+_8949669 | 5.46 |
ENSMUST00000060369.4
|
Nxph1
|
neurexophilin 1 |
chr8_+_114932312 | 5.46 |
ENSMUST00000049509.7
ENSMUST00000150963.2 |
Vat1l
|
vesicle amine transport protein 1 like |
chr10_-_63926044 | 5.45 |
ENSMUST00000105439.2
|
Lrrtm3
|
leucine rich repeat transmembrane neuronal 3 |
chr18_+_86729645 | 5.42 |
ENSMUST00000122464.8
|
Cbln2
|
cerebellin 2 precursor protein |
chr4_-_60697274 | 5.40 |
ENSMUST00000117932.2
|
Mup12
|
major urinary protein 12 |
chr6_+_77219627 | 5.38 |
ENSMUST00000159616.2
|
Lrrtm1
|
leucine rich repeat transmembrane neuronal 1 |
chr13_+_58955675 | 5.34 |
ENSMUST00000224402.2
|
Ntrk2
|
neurotrophic tyrosine kinase, receptor, type 2 |
chr6_+_77219698 | 5.20 |
ENSMUST00000161677.2
|
Lrrtm1
|
leucine rich repeat transmembrane neuronal 1 |
chr14_+_65504067 | 5.17 |
ENSMUST00000224629.2
|
Fbxo16
|
F-box protein 16 |
chr15_-_37459570 | 5.16 |
ENSMUST00000119730.8
ENSMUST00000120746.8 |
Ncald
|
neurocalcin delta |
chr13_+_83672654 | 5.14 |
ENSMUST00000199019.5
|
Mef2c
|
myocyte enhancer factor 2C |
chr9_+_109865810 | 5.14 |
ENSMUST00000163190.8
|
Map4
|
microtubule-associated protein 4 |
chr14_+_65504151 | 5.12 |
ENSMUST00000169656.3
ENSMUST00000226005.2 |
Fbxo16
|
F-box protein 16 |
chr6_+_58810674 | 5.10 |
ENSMUST00000041401.11
|
Herc3
|
hect domain and RLD 3 |
chr4_+_101407608 | 5.09 |
ENSMUST00000094953.11
ENSMUST00000106933.2 |
Dnajc6
|
DnaJ heat shock protein family (Hsp40) member C6 |
chr3_+_68479578 | 5.06 |
ENSMUST00000170788.9
|
Schip1
|
schwannomin interacting protein 1 |
chr18_+_37568647 | 4.87 |
ENSMUST00000055495.6
|
Pcdhb12
|
protocadherin beta 12 |
chr18_+_37952556 | 4.87 |
ENSMUST00000055935.11
|
Pcdhgc5
|
protocadherin gamma subfamily C, 5 |
chr18_+_86729184 | 4.83 |
ENSMUST00000068423.10
|
Cbln2
|
cerebellin 2 precursor protein |
chr5_-_122140403 | 4.77 |
ENSMUST00000134326.2
|
Cux2
|
cut-like homeobox 2 |
chr5_+_137059127 | 4.77 |
ENSMUST00000041543.9
ENSMUST00000186451.2 |
Vgf
|
VGF nerve growth factor inducible |
chr12_+_29584560 | 4.76 |
ENSMUST00000021009.10
|
Myt1l
|
myelin transcription factor 1-like |
chr1_-_5140504 | 4.69 |
ENSMUST00000147158.2
ENSMUST00000118000.8 |
Rgs20
|
regulator of G-protein signaling 20 |
chr7_+_131568167 | 4.66 |
ENSMUST00000045840.5
|
Gpr26
|
G protein-coupled receptor 26 |
chr14_-_109151590 | 4.54 |
ENSMUST00000100322.4
|
Slitrk1
|
SLIT and NTRK-like family, member 1 |
chr18_-_61147272 | 4.51 |
ENSMUST00000025520.10
|
Slc6a7
|
solute carrier family 6 (neurotransmitter transporter, L-proline), member 7 |
chr5_-_87074380 | 4.48 |
ENSMUST00000031183.3
|
Ugt2b1
|
UDP glucuronosyltransferase 2 family, polypeptide B1 |
chr6_-_77956499 | 4.47 |
ENSMUST00000159626.8
ENSMUST00000075340.12 ENSMUST00000162273.2 |
Ctnna2
|
catenin (cadherin associated protein), alpha 2 |
chr18_+_37622518 | 4.40 |
ENSMUST00000055949.4
|
Pcdhb18
|
protocadherin beta 18 |
chr10_-_70491764 | 4.27 |
ENSMUST00000162144.2
ENSMUST00000162793.8 |
Phyhipl
|
phytanoyl-CoA hydroxylase interacting protein-like |
chr8_+_12999394 | 4.25 |
ENSMUST00000110867.9
|
Mcf2l
|
mcf.2 transforming sequence-like |
chr3_-_146487102 | 4.25 |
ENSMUST00000005164.12
|
Prkacb
|
protein kinase, cAMP dependent, catalytic, beta |
chr5_-_135494775 | 4.21 |
ENSMUST00000212301.2
|
Hip1
|
huntingtin interacting protein 1 |
chr14_-_80008745 | 4.18 |
ENSMUST00000039568.11
ENSMUST00000195355.2 |
Pcdh8
|
protocadherin 8 |
chr8_+_12999480 | 4.17 |
ENSMUST00000110866.9
|
Mcf2l
|
mcf.2 transforming sequence-like |
chr10_-_109669053 | 4.14 |
ENSMUST00000238286.2
|
Nav3
|
neuron navigator 3 |
chr1_-_189902868 | 4.04 |
ENSMUST00000177288.4
ENSMUST00000175916.8 |
Prox1
|
prospero homeobox 1 |
chrX_-_58211440 | 4.01 |
ENSMUST00000119306.2
|
Fgf13
|
fibroblast growth factor 13 |
chr1_-_110905082 | 3.98 |
ENSMUST00000094626.5
|
Cdh19
|
cadherin 19, type 2 |
chr3_-_19749489 | 3.82 |
ENSMUST00000061294.5
|
Crh
|
corticotropin releasing hormone |
chrM_+_10167 | 3.82 |
ENSMUST00000082414.1
|
mt-Nd4
|
mitochondrially encoded NADH dehydrogenase 4 |
chr6_+_134958681 | 3.80 |
ENSMUST00000167323.3
|
Apold1
|
apolipoprotein L domain containing 1 |
chr17_-_43978056 | 3.79 |
ENSMUST00000024705.6
|
Slc25a27
|
solute carrier family 25, member 27 |
chr18_+_37952596 | 3.77 |
ENSMUST00000193890.2
ENSMUST00000193941.2 |
Pcdhgc5
|
protocadherin gamma subfamily C, 5 |
chr14_-_51134906 | 3.74 |
ENSMUST00000170855.2
|
Klhl33
|
kelch-like 33 |
chr18_+_57605525 | 3.74 |
ENSMUST00000209786.2
|
Ctxn3
|
cortexin 3 |
chr6_+_97187650 | 3.71 |
ENSMUST00000044681.7
|
Arl6ip5
|
ADP-ribosylation factor-like 6 interacting protein 5 |
chr2_+_71359000 | 3.71 |
ENSMUST00000126400.2
|
Dlx1
|
distal-less homeobox 1 |
chr12_+_38830081 | 3.69 |
ENSMUST00000095767.11
|
Etv1
|
ets variant 1 |
chr2_-_57003064 | 3.69 |
ENSMUST00000112627.2
|
Nr4a2
|
nuclear receptor subfamily 4, group A, member 2 |
chr6_-_102441628 | 3.64 |
ENSMUST00000032159.7
|
Cntn3
|
contactin 3 |
chr5_-_36771074 | 3.61 |
ENSMUST00000132383.6
ENSMUST00000174019.2 |
D5Ertd579e
Gm42936
|
DNA segment, Chr 5, ERATO Doi 579, expressed predicted gene 42936 |
chr9_+_44309727 | 3.61 |
ENSMUST00000213268.2
|
Slc37a4
|
solute carrier family 37 (glucose-6-phosphate transporter), member 4 |
chr12_+_29578354 | 3.57 |
ENSMUST00000218583.2
ENSMUST00000049784.17 |
Myt1l
|
myelin transcription factor 1-like |
chr12_+_103524690 | 3.56 |
ENSMUST00000187155.7
|
Ppp4r4
|
protein phosphatase 4, regulatory subunit 4 |
chr18_+_37898633 | 3.54 |
ENSMUST00000044851.8
|
Pcdhga12
|
protocadherin gamma subfamily A, 12 |
chr12_-_41536430 | 3.52 |
ENSMUST00000043884.6
|
Lrrn3
|
leucine rich repeat protein 3, neuronal |
chr2_-_115896279 | 3.47 |
ENSMUST00000110907.8
ENSMUST00000110908.9 |
Meis2
|
Meis homeobox 2 |
chr6_-_124790029 | 3.46 |
ENSMUST00000149610.3
|
Tpi1
|
triosephosphate isomerase 1 |
chr12_+_69954506 | 3.45 |
ENSMUST00000223456.2
|
Atl1
|
atlastin GTPase 1 |
chr1_-_67077906 | 3.39 |
ENSMUST00000119559.8
ENSMUST00000149996.2 ENSMUST00000027149.12 ENSMUST00000113979.10 |
Lancl1
|
LanC (bacterial lantibiotic synthetase component C)-like 1 |
chr1_-_158183894 | 3.38 |
ENSMUST00000004133.11
|
Brinp2
|
bone morphogenic protein/retinoic acid inducible neural-specific 2 |
chr8_+_22996233 | 3.37 |
ENSMUST00000210854.2
|
Slc20a2
|
solute carrier family 20, member 2 |
chr1_+_179938904 | 3.35 |
ENSMUST00000145181.2
|
Cdc42bpa
|
CDC42 binding protein kinase alpha |
chr17_+_6057868 | 3.34 |
ENSMUST00000115785.8
|
Synj2
|
synaptojanin 2 |
chr14_-_36820304 | 3.33 |
ENSMUST00000022337.11
|
Cdhr1
|
cadherin-related family member 1 |
chr5_+_137059522 | 3.27 |
ENSMUST00000187382.2
|
Vgf
|
VGF nerve growth factor inducible |
chr10_+_127256192 | 3.23 |
ENSMUST00000171434.8
|
R3hdm2
|
R3H domain containing 2 |
chr10_+_127337541 | 3.21 |
ENSMUST00000160019.8
ENSMUST00000160610.2 ENSMUST00000035839.3 |
Stac3
|
SH3 and cysteine rich domain 3 |
chr13_+_83672389 | 3.20 |
ENSMUST00000200394.5
|
Mef2c
|
myocyte enhancer factor 2C |
chr2_+_20742115 | 3.19 |
ENSMUST00000114606.8
ENSMUST00000114608.3 |
Etl4
|
enhancer trap locus 4 |
chr8_+_47439916 | 3.16 |
ENSMUST00000039840.15
|
Enpp6
|
ectonucleotide pyrophosphatase/phosphodiesterase 6 |
chr4_+_101365144 | 3.16 |
ENSMUST00000149047.8
ENSMUST00000106929.10 |
Dnajc6
|
DnaJ heat shock protein family (Hsp40) member C6 |
chr2_+_174169351 | 3.08 |
ENSMUST00000124935.8
|
Gnas
|
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
chr16_-_96971905 | 3.08 |
ENSMUST00000056102.9
|
Dscam
|
DS cell adhesion molecule |
chr8_+_47439948 | 3.07 |
ENSMUST00000119686.2
|
Enpp6
|
ectonucleotide pyrophosphatase/phosphodiesterase 6 |
chrX_+_65696608 | 3.03 |
ENSMUST00000036043.5
|
Slitrk2
|
SLIT and NTRK-like family, member 2 |
chr8_-_68658694 | 2.90 |
ENSMUST00000212960.2
|
Psd3
|
pleckstrin and Sec7 domain containing 3 |
chr5_-_124325213 | 2.88 |
ENSMUST00000161938.8
|
Pitpnm2
|
phosphatidylinositol transfer protein, membrane-associated 2 |
chr7_+_51528715 | 2.87 |
ENSMUST00000051912.13
|
Gas2
|
growth arrest specific 2 |
chr9_-_49710190 | 2.86 |
ENSMUST00000114476.8
ENSMUST00000193547.6 |
Ncam1
|
neural cell adhesion molecule 1 |
chr2_-_5680801 | 2.84 |
ENSMUST00000114987.4
|
Camk1d
|
calcium/calmodulin-dependent protein kinase ID |
chr6_+_106095726 | 2.81 |
ENSMUST00000113258.8
ENSMUST00000079416.6 |
Cntn4
|
contactin 4 |
chr2_+_174169539 | 2.79 |
ENSMUST00000133356.8
ENSMUST00000087871.11 |
Gnas
|
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
chrX_+_20554193 | 2.74 |
ENSMUST00000115364.8
|
Cdk16
|
cyclin-dependent kinase 16 |
chr17_-_43978023 | 2.73 |
ENSMUST00000233442.2
|
Slc25a27
|
solute carrier family 25, member 27 |
chr5_+_30972067 | 2.71 |
ENSMUST00000200692.4
|
Mapre3
|
microtubule-associated protein, RP/EB family, member 3 |
chr17_-_82045800 | 2.70 |
ENSMUST00000235015.2
ENSMUST00000163123.3 |
Slc8a1
|
solute carrier family 8 (sodium/calcium exchanger), member 1 |
chr2_-_62404195 | 2.66 |
ENSMUST00000174234.8
ENSMUST00000000402.16 ENSMUST00000174448.8 ENSMUST00000102732.10 |
Fap
|
fibroblast activation protein |
chr4_-_134099840 | 2.64 |
ENSMUST00000030643.3
|
Extl1
|
exostosin-like glycosyltransferase 1 |
chr8_-_85663976 | 2.64 |
ENSMUST00000109741.9
ENSMUST00000119820.2 |
Mast1
|
microtubule associated serine/threonine kinase 1 |
chr18_+_37433852 | 2.63 |
ENSMUST00000051754.2
|
Pcdhb3
|
protocadherin beta 3 |
chr2_+_174169492 | 2.61 |
ENSMUST00000156623.8
ENSMUST00000149016.9 |
Gnas
|
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
chr9_-_49710058 | 2.59 |
ENSMUST00000192584.2
ENSMUST00000166811.9 |
Ncam1
|
neural cell adhesion molecule 1 |
chr9_-_121621544 | 2.57 |
ENSMUST00000035110.11
|
Hhatl
|
hedgehog acyltransferase-like |
chr1_-_163141230 | 2.56 |
ENSMUST00000174397.3
ENSMUST00000075805.13 |
Prrx1
|
paired related homeobox 1 |
chr8_+_46984016 | 2.53 |
ENSMUST00000152423.2
|
Acsl1
|
acyl-CoA synthetase long-chain family member 1 |
chr2_-_77349909 | 2.52 |
ENSMUST00000111830.9
|
Zfp385b
|
zinc finger protein 385B |
chr6_-_12749409 | 2.50 |
ENSMUST00000119581.7
|
Thsd7a
|
thrombospondin, type I, domain containing 7A |
chr6_+_132824105 | 2.46 |
ENSMUST00000071696.2
|
Tas2r123
|
taste receptor, type 2, member 123 |
chr18_+_65158873 | 2.41 |
ENSMUST00000226058.2
|
Nedd4l
|
neural precursor cell expressed, developmentally down-regulated gene 4-like |
chrX_+_47712614 | 2.39 |
ENSMUST00000114936.8
|
Slc25a14
|
solute carrier family 25 (mitochondrial carrier, brain), member 14 |
chr12_+_84408803 | 2.37 |
ENSMUST00000110278.8
ENSMUST00000145522.2 |
Coq6
|
coenzyme Q6 monooxygenase |
chr1_+_178356678 | 2.36 |
ENSMUST00000161017.8
|
Kif26b
|
kinesin family member 26B |
chr2_-_86810298 | 2.33 |
ENSMUST00000117211.3
|
Olfr1100
|
olfactory receptor 1100 |
chr4_+_86493905 | 2.31 |
ENSMUST00000091064.8
|
Rraga
|
Ras-related GTP binding A |
chr14_+_117162791 | 2.31 |
ENSMUST00000088483.10
|
Gpc6
|
glypican 6 |
chr6_-_116084810 | 2.31 |
ENSMUST00000204353.3
|
Tmcc1
|
transmembrane and coiled coil domains 1 |
chr7_+_51528788 | 2.25 |
ENSMUST00000107591.9
|
Gas2
|
growth arrest specific 2 |
chr1_+_143615294 | 2.25 |
ENSMUST00000185362.7
ENSMUST00000111957.10 ENSMUST00000145571.2 |
Glrx2
|
glutaredoxin 2 (thioltransferase) |
chr12_-_84408576 | 2.25 |
ENSMUST00000021659.2
ENSMUST00000065536.9 |
Fam161b
|
family with sequence similarity 161, member B |
chr2_-_79959802 | 2.24 |
ENSMUST00000102653.8
|
Pde1a
|
phosphodiesterase 1A, calmodulin-dependent |
chr11_-_98620200 | 2.22 |
ENSMUST00000126565.2
ENSMUST00000100500.9 ENSMUST00000017354.13 |
Med24
|
mediator complex subunit 24 |
chr1_+_53100796 | 2.22 |
ENSMUST00000027269.7
ENSMUST00000191197.2 |
Mstn
|
myostatin |
chr10_+_69370038 | 2.22 |
ENSMUST00000182439.8
ENSMUST00000092434.12 ENSMUST00000047061.13 ENSMUST00000092432.12 ENSMUST00000092431.12 ENSMUST00000054167.15 |
Ank3
|
ankyrin 3, epithelial |
chr16_-_36810810 | 2.21 |
ENSMUST00000075869.13
|
Fbxo40
|
F-box protein 40 |
chr3_+_5283606 | 2.18 |
ENSMUST00000026284.13
|
Zfhx4
|
zinc finger homeodomain 4 |
chr6_+_63232955 | 2.16 |
ENSMUST00000095852.5
|
Grid2
|
glutamate receptor, ionotropic, delta 2 |
chr9_+_74959259 | 2.15 |
ENSMUST00000170310.2
ENSMUST00000166549.2 |
Arpp19
|
cAMP-regulated phosphoprotein 19 |
chr18_+_23885390 | 2.14 |
ENSMUST00000170802.8
ENSMUST00000155708.8 ENSMUST00000118826.9 |
Mapre2
|
microtubule-associated protein, RP/EB family, member 2 |
chr7_-_142215595 | 2.14 |
ENSMUST00000145896.3
|
Igf2
|
insulin-like growth factor 2 |
chr4_+_150322151 | 2.11 |
ENSMUST00000141931.2
|
Eno1
|
enolase 1, alpha non-neuron |
chr6_-_39787813 | 2.06 |
ENSMUST00000114797.2
ENSMUST00000031978.9 |
Mrps33
|
mitochondrial ribosomal protein S33 |
chr11_-_116080361 | 2.03 |
ENSMUST00000148601.2
|
Acox1
|
acyl-Coenzyme A oxidase 1, palmitoyl |
chr19_-_60862964 | 1.99 |
ENSMUST00000025961.7
|
Prdx3
|
peroxiredoxin 3 |
chr7_-_121700958 | 1.98 |
ENSMUST00000139456.2
ENSMUST00000106471.9 ENSMUST00000123296.8 ENSMUST00000033157.10 |
Ndufab1
|
NADH:ubiquinone oxidoreductase subunit AB1 |
chr12_+_84408742 | 1.98 |
ENSMUST00000021661.13
|
Coq6
|
coenzyme Q6 monooxygenase |
chr12_-_80807454 | 1.96 |
ENSMUST00000073251.8
|
Ccdc177
|
coiled-coil domain containing 177 |
chr3_-_151953894 | 1.96 |
ENSMUST00000196529.5
|
Nexn
|
nexilin |
chr18_+_37580692 | 1.95 |
ENSMUST00000052387.5
|
Pcdhb14
|
protocadherin beta 14 |
chr6_-_39354570 | 1.95 |
ENSMUST00000200771.4
ENSMUST00000202204.4 ENSMUST00000202952.2 ENSMUST00000202400.4 ENSMUST00000200969.4 ENSMUST00000202749.4 ENSMUST00000090243.8 |
Slc37a3
|
solute carrier family 37 (glycerol-3-phosphate transporter), member 3 |
chr9_+_77543776 | 1.89 |
ENSMUST00000057781.8
|
Klhl31
|
kelch-like 31 |
chr11_+_67090878 | 1.88 |
ENSMUST00000124516.8
ENSMUST00000018637.15 ENSMUST00000129018.8 |
Myh1
|
myosin, heavy polypeptide 1, skeletal muscle, adult |
chr1_+_42734051 | 1.88 |
ENSMUST00000239323.2
ENSMUST00000199521.5 ENSMUST00000176807.3 |
Pou3f3
Gm20646
|
POU domain, class 3, transcription factor 3 predicted gene 20646 |
chr11_-_99213769 | 1.81 |
ENSMUST00000038004.3
|
Krt25
|
keratin 25 |
chr1_-_93406091 | 1.79 |
ENSMUST00000188165.2
|
Hdlbp
|
high density lipoprotein (HDL) binding protein |
chr6_+_29467717 | 1.79 |
ENSMUST00000004396.13
|
Atp6v1f
|
ATPase, H+ transporting, lysosomal V1 subunit F |
chrX_+_47712676 | 1.77 |
ENSMUST00000177710.2
|
Slc25a14
|
solute carrier family 25 (mitochondrial carrier, brain), member 14 |
chr5_-_146157711 | 1.74 |
ENSMUST00000169407.9
ENSMUST00000161331.8 ENSMUST00000159074.3 ENSMUST00000067837.10 |
Rnf6
|
ring finger protein (C3H2C3 type) 6 |
chr18_+_37440497 | 1.73 |
ENSMUST00000056712.4
|
Pcdhb4
|
protocadherin beta 4 |
chr11_+_103857541 | 1.67 |
ENSMUST00000057921.10
ENSMUST00000063347.12 |
Arf2
|
ADP-ribosylation factor 2 |
chr3_+_5283577 | 1.65 |
ENSMUST00000175866.8
|
Zfhx4
|
zinc finger homeodomain 4 |
chr5_-_113044216 | 1.65 |
ENSMUST00000086617.11
|
Myo18b
|
myosin XVIIIb |
chrX_+_7563370 | 1.64 |
ENSMUST00000049896.13
|
Gpkow
|
G patch domain and KOW motifs |
chr2_+_3115250 | 1.57 |
ENSMUST00000072955.12
|
Fam171a1
|
family with sequence similarity 171, member A1 |
chr11_-_43727071 | 1.57 |
ENSMUST00000167574.2
|
Adra1b
|
adrenergic receptor, alpha 1b |
chr11_+_108814007 | 1.55 |
ENSMUST00000106711.2
|
Axin2
|
axin 2 |
chr14_-_70879694 | 1.55 |
ENSMUST00000227123.2
ENSMUST00000022697.7 |
Fgf17
|
fibroblast growth factor 17 |
chr11_+_67061908 | 1.55 |
ENSMUST00000018641.8
|
Myh2
|
myosin, heavy polypeptide 2, skeletal muscle, adult |
chr6_+_29468067 | 1.49 |
ENSMUST00000143101.4
ENSMUST00000149646.3 |
Atp6v1f
|
ATPase, H+ transporting, lysosomal V1 subunit F |
chr12_+_38833501 | 1.46 |
ENSMUST00000159334.8
|
Etv1
|
ets variant 1 |
chr8_-_45747883 | 1.42 |
ENSMUST00000026907.6
|
Klkb1
|
kallikrein B, plasma 1 |
chr14_+_47069667 | 1.41 |
ENSMUST00000140114.3
ENSMUST00000133989.8 |
Cgrrf1
|
cell growth regulator with ring finger domain 1 |
chr6_+_87405968 | 1.36 |
ENSMUST00000032125.7
|
Bmp10
|
bone morphogenetic protein 10 |
chr7_+_65343156 | 1.36 |
ENSMUST00000032726.14
ENSMUST00000107495.5 ENSMUST00000143508.3 ENSMUST00000129166.3 ENSMUST00000206517.2 ENSMUST00000206837.2 ENSMUST00000206628.2 ENSMUST00000206361.2 |
Tm2d3
|
TM2 domain containing 3 |
chr18_+_69633741 | 1.32 |
ENSMUST00000207214.2
ENSMUST00000201094.4 ENSMUST00000200703.4 ENSMUST00000202765.4 |
Tcf4
|
transcription factor 4 |
chr12_+_38833454 | 1.30 |
ENSMUST00000161980.8
ENSMUST00000160701.8 |
Etv1
|
ets variant 1 |
chr10_+_4561974 | 1.23 |
ENSMUST00000105590.8
ENSMUST00000067086.14 |
Esr1
|
estrogen receptor 1 (alpha) |
chr4_+_119671688 | 1.21 |
ENSMUST00000106307.9
|
Hivep3
|
human immunodeficiency virus type I enhancer binding protein 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 18.7 | GO:0099538 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
2.8 | 14.0 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
2.1 | 30.0 | GO:0099628 | receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) |
2.1 | 28.8 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
1.9 | 5.7 | GO:1903002 | regulation of lipid transport across blood brain barrier(GO:1903000) positive regulation of lipid transport across blood brain barrier(GO:1903002) |
1.5 | 4.5 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
1.4 | 8.2 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
1.4 | 5.5 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
1.3 | 4.0 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
1.3 | 6.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
1.3 | 3.8 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
1.2 | 6.2 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
1.2 | 11.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
1.2 | 3.7 | GO:0021893 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
1.2 | 3.5 | GO:0046166 | alditol catabolic process(GO:0019405) glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
1.1 | 4.5 | GO:0035524 | proline transmembrane transport(GO:0035524) |
1.1 | 4.2 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
1.1 | 23.1 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
1.0 | 7.3 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.0 | 3.1 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.9 | 8.5 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.9 | 3.7 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.9 | 3.6 | GO:0080163 | regulation of protein serine/threonine phosphatase activity(GO:0080163) |
0.9 | 2.7 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) melanocyte proliferation(GO:0097325) |
0.9 | 2.6 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.7 | 3.7 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.7 | 5.1 | GO:0051012 | microtubule sliding(GO:0051012) |
0.7 | 8.3 | GO:0003172 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.7 | 6.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.7 | 2.7 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.7 | 16.0 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.7 | 10.6 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.6 | 4.0 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.6 | 11.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.6 | 2.2 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.5 | 11.0 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.5 | 1.6 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
0.5 | 1.9 | GO:0072021 | ascending thin limb development(GO:0072021) thick ascending limb development(GO:0072023) metanephric ascending thin limb development(GO:0072218) metanephric thick ascending limb development(GO:0072233) |
0.4 | 8.0 | GO:0043084 | penile erection(GO:0043084) |
0.4 | 3.6 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.4 | 7.4 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.4 | 19.6 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.4 | 15.0 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.4 | 8.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.3 | 2.0 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.3 | 2.4 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.3 | 4.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.3 | 1.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.3 | 2.7 | GO:0071313 | cellular response to caffeine(GO:0071313) positive regulation of the force of heart contraction(GO:0098735) |
0.3 | 5.4 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.3 | 2.0 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.3 | 1.4 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.3 | 0.8 | GO:1990180 | mitochondrial tRNA 3'-end processing(GO:1990180) |
0.3 | 6.6 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.3 | 1.6 | GO:2000054 | regulation of mismatch repair(GO:0032423) regulation of chondrocyte development(GO:0061181) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.3 | 2.3 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.2 | 1.7 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 1.2 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.2 | 2.2 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 8.9 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 3.8 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 0.2 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.2 | 26.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 21.9 | GO:0007416 | synapse assembly(GO:0007416) |
0.2 | 1.0 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 0.6 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.2 | 5.2 | GO:0001553 | luteinization(GO:0001553) |
0.2 | 6.0 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.2 | 3.3 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.2 | 2.1 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.2 | 2.8 | GO:0048664 | neuron fate determination(GO:0048664) |
0.2 | 1.4 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.2 | 1.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.2 | 2.5 | GO:0044539 | adiponectin-activated signaling pathway(GO:0033211) long-chain fatty acid import(GO:0044539) |
0.1 | 2.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 7.6 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 13.3 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 3.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 1.6 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 1.0 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 3.3 | GO:0040023 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.1 | 0.4 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.9 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 8.7 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.1 | 0.8 | GO:0097475 | motor neuron migration(GO:0097475) |
0.1 | 0.8 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 4.2 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) |
0.1 | 1.1 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 2.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 2.7 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 0.4 | GO:0050973 | detection of mechanical stimulus involved in equilibrioception(GO:0050973) |
0.1 | 2.8 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 2.5 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 5.8 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 3.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 2.6 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 2.1 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 0.2 | GO:0003032 | detection of oxygen(GO:0003032) |
0.1 | 0.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) positive regulation of glucokinase activity(GO:0033133) |
0.1 | 0.7 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 3.4 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 8.3 | GO:0050808 | synapse organization(GO:0050808) |
0.1 | 7.4 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.0 | 1.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.5 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.0 | 3.2 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.7 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.0 | 4.4 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
0.0 | 1.3 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 4.7 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.3 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.0 | 0.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 7.2 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.0 | 0.2 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.0 | 0.9 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.6 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.0 | 0.6 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 1.8 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 2.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 2.7 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
0.0 | 0.6 | GO:0048665 | neuron fate specification(GO:0048665) |
0.0 | 0.7 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.0 | 0.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.6 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 4.2 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.0 | 1.6 | GO:0001756 | somitogenesis(GO:0001756) |
0.0 | 0.2 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.0 | 1.2 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 0.4 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 2.8 | GO:0045665 | negative regulation of neuron differentiation(GO:0045665) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.5 | 30.0 | GO:0099573 | glutamatergic postsynaptic density(GO:0099573) |
3.5 | 17.3 | GO:0044308 | axonal spine(GO:0044308) |
1.1 | 5.7 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.8 | 4.2 | GO:0098890 | extrinsic component of postsynaptic membrane(GO:0098890) |
0.5 | 2.3 | GO:1990131 | Iml1 complex(GO:1990130) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.4 | 26.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 2.7 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.3 | 2.7 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.3 | 3.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.3 | 4.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 3.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 3.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 8.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 0.6 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.2 | 6.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 1.2 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.2 | 2.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 7.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.2 | 2.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 2.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.1 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
0.1 | 0.6 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.1 | 1.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 3.8 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 1.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 9.8 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 11.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 4.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.6 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 27.2 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 12.8 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 11.5 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 2.2 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 28.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 8.0 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.3 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.1 | 6.8 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 2.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 3.4 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.7 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 14.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.5 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 1.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 5.3 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 4.6 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 3.6 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 5.3 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 8.0 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 9.8 | GO:0030017 | sarcomere(GO:0030017) |
0.0 | 4.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 2.4 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 0.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.2 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.0 | 0.2 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.0 | 14.5 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 4.7 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 35.7 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 0.1 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.0 | 0.8 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 4.7 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.3 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.6 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 18.7 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
2.2 | 17.3 | GO:1904315 | AMPA glutamate receptor activity(GO:0004971) neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
1.9 | 5.7 | GO:0046911 | metal chelating activity(GO:0046911) |
1.9 | 30.0 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
1.5 | 23.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.2 | 3.6 | GO:0015152 | glucose-6-phosphate transmembrane transporter activity(GO:0015152) |
1.0 | 7.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.0 | 17.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.0 | 3.8 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.9 | 2.7 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.9 | 2.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.9 | 28.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.8 | 8.5 | GO:0051430 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.7 | 7.0 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.7 | 3.4 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.7 | 2.0 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.6 | 6.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.5 | 2.5 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
0.5 | 11.8 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.5 | 4.5 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.4 | 1.2 | GO:0038052 | type 1 metabotropic glutamate receptor binding(GO:0031798) RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.4 | 4.0 | GO:0050692 | DBD domain binding(GO:0050692) |
0.4 | 1.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.4 | 4.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 9.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.4 | 4.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.3 | 3.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 13.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 1.6 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.3 | 8.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 2.0 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.3 | 8.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.3 | 3.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.3 | 0.8 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 5.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 8.2 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 0.6 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
0.2 | 8.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 2.2 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.2 | 1.0 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.2 | 11.6 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 1.1 | GO:0001602 | peptide YY receptor activity(GO:0001601) pancreatic polypeptide receptor activity(GO:0001602) |
0.2 | 2.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 1.2 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 2.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 2.7 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 16.0 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 1.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 4.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 9.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 2.6 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 4.3 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 3.8 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 2.2 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 5.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 3.4 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 4.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.6 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 1.4 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.7 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.1 | 4.0 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 3.3 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 2.3 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.4 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.1 | 1.6 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 1.3 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 1.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 1.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 2.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.2 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 4.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 0.9 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 2.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 8.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 2.7 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.6 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 17.4 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 1.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.2 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.0 | 1.0 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 2.5 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.7 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 15.6 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.6 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 2.3 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.8 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 7.6 | GO:0042277 | peptide binding(GO:0042277) |
0.0 | 1.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 1.7 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 2.3 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 5.2 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.0 | 0.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.3 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 7.7 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.0 | 1.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 30.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.7 | 28.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 26.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 7.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 17.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 8.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 7.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 6.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 4.7 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 7.0 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 5.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 1.6 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 1.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 3.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 2.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 1.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 3.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 2.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 1.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 1.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 1.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 47.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.4 | 6.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.3 | 20.6 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.3 | 5.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 7.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.3 | 5.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 8.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 4.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 3.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 3.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 10.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 4.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 8.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 7.5 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 5.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 2.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 5.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 13.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 20.9 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.1 | 2.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 2.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 3.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 3.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.6 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 1.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 3.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 11.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 1.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 1.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 3.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 1.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 2.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 1.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |